Tirzepatide powder, or tirze raw is offered in high quality raw powder form. We also offer Tirzepatide in sterile vials, 2mg/vial, 5mg/vial, 10mg/vial and above (custom-made required), 15mg/vial ~ 60mg/vial. For more details, please contact us.
Tirzepatide is used for weight loss, it is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss, for helping lose weight and keep weight off. Tirzepatide is administered via subcutaneous injections (under the skin). It is sold under the brand names Mounjaro for diabetes treatment,and Zepbound for weight loss.
Tirzepatide is a gastric inhibitory polypeptide analog and GLP-1 receptor agonist. The most common side effects include nausea, vomiting, diarrhea, decreased appetite, constipation, upper abdominal discomfort, and abdominal pain.
Tirzepatide was approved for treatment of diabetes in the United States in May 2022, in the European Union in September 2022, in Canada in November 2022, and in Australia in December 2022. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. It was approved by the FDA for weight loss in November 2023. In November 2023, the UK Medicines and Healthcare products Regulatory Agency revised the indication for tirzepatide to include treatment for weight loss.
Reviews
There are no reviews yet.